ArticleClinical therapeutics2016

EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.

Guntram Schernthaner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.